期刊文献+

人脑星形细胞瘤组织中NF-κB的DNA结合活性

DNA Binding Activity of Nuclear Factor-Kappa B in Human Astrocytoma
下载PDF
导出
摘要 背景与目的:人类肿瘤细胞的转录因子可在转录水平调控许多恶性相关基因的表达,与肿瘤细胞的低分化和高转移有关,并抑制肿瘤细胞凋亡。本研究旨在观察人脑星形细胞瘤组织中核因子-κB(nuclearfactor-kappaB,NF-κB)的DNA结合活性,探讨其在人脑星形细胞瘤发生和发展中的意义。方法:采用电泳迁移率(electrophoreticmobilityshiftassay,EMSA)同位素放射自显影方法分别检测12例正常脑组织及37例人脑星形细胞瘤组织中NF-κB的DNA结合活性。结果:NF-κB的DNA结合活性在人脑星形细胞瘤组织光密度值为134.2±24.1,高于正常脑组织的97.5±1.9(P<0.05),其中多形胶质母细胞瘤(Ⅳ级)NF-κB的DNA结合活性最高,为106.8±7.4,依次为间变性星形细胞瘤(Ⅲ级)123.2±10.1,星形母细胞瘤(Ⅱ级)139.3±16.8,星形细胞瘤(Ⅰ级)160.2±18.6(P<0.05)。结论:NF-κB的DNA结合活性与人脑星形细胞瘤分级有关,并随恶性程度增加而增强。 BACKGROUND &OBJECTIVE: Transcription factors of human cancer cells can regulate the expression of many malignancy-related gene products, relate t o poor differentiation, and high metastasis of cancer cells, and also inhibit ap optosis of cancer cells. This study was designed to investigate the nuclear fact or-kappa B (NF-闎) DNA binding activity in human astrocytoma tissue, and its significance with human astrocytoma development. METHODS: The NF-闎 DNA bindin g activities of 12 cases of normal brain tissue, and 37 cases of human astrocyto ma tissue were detected by electrophoretic mobility shift assay (EMSA),and photo densitometry. RESULTS: The absorbency of NF-闎 DNA binding activity in human astrocytoma tissue was 134 2±24 1,higher than that in normal brain tissue (97 5±1 9)(P< 0 05). The NF-闎 DNA binding activity in multiform glioblastoma tissue was highest (106 8±7 4), that in anaplasia Astrocytoma was 123 2±10 1, in astroblastoma was 139 3±16 8, and in astrocytoma was 160 2±18 6 ( P< 0 05). CONCLUSION:The NF-闎 DNA binding activity correlates with malignan cy degree of human astrocytoma.
出处 《癌症》 SCIE CAS CSCD 北大核心 2004年第10期1207-1209,共3页 Chinese Journal of Cancer
基金 山东省科委重点课题(No.2240)~~
关键词 DNA结合活性 人脑星形细胞瘤 NF-ΚB 瘤组织 瘤细胞 正常 脑组织 转录水平 恶性相关基因 变性 Nuclear factor-kappa B (NF-闎) Human astrocytoma Electropho-re tic mobility shift assay (EMSA) Autoradiography
  • 相关文献

参考文献10

  • 1Thomassen M J, Kavuru MS. Human alveolar macrophages and monocytes as a source and target for nitric oxide [J] .Int Immunopharmacol, 2001, 1 (8): 1479-1490.
  • 2Kim IY, Stadtman TC. Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment [J]. Proc Natl Acad Sci USA, 1997, 94(24): 12904-12907.
  • 3Nishiya T, Uehara T, Kaneko M, et al. Involvement of nuclear factor-kappaB(NF-kappaB) signaling in the expression of inducible nitric oxide synthase(iNOS) gene in rat C6 glioma cells[J]. Biochem Biophys Res Commun, 2000, 275(2): 268-273.
  • 4Hernandez M, de Arriba AF, Merlos M, et al. Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappaB-dependent transcription in human astrocytoma cells [J].Br J Pharmacol, 2001, 132(2): 547-555.
  • 5Li QQ, Bever CT. Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells [J]. Brain Res Mol Brain Res, 2001, 87 (1): 48-60.
  • 6Kemler I, Fontana A. Role of IkappaBalpha and IkappaBbeta in the biphasic nuclear translocation of NF-kappaB in TNFalphastimulated astrocytes and in neuroblastoma cells [J]. Glia, 1999,26(3): 212-220.
  • 7Ichiyama T, Campbell IL, Furukawa S, et al. Autocrine alphamelanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma [J]. J Neurosci Res, 1999, 58(5): 684-689.
  • 8Nagai S, Washiyama K, Kurimoto M, et al. Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma [J]. J Neurosurg, 2002, 96 (5): 909-917.
  • 9王维,罗和生,余保平.人胃癌及癌前病变中NF-KappaB和c-myc蛋白的表达与意义[J].肿瘤防治研究,2002,29(4):285-287. 被引量:30
  • 10Bours V, Bonizzi G, Bentires-Alj M, et al. NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment [J]. Toxicology, 2000, 153(1-3):27-38.

二级参考文献1

  • 1张佩范 张荫昌.胃癌.胃癌病理及胃粘膜活检[M].沈阳:辽宁科学技术出版社,1988.75-98.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部